Dr. Nick Zdenkowski discusses the ZEST trial.
00:35 - Identification of circulating tumor DNA in early-stage breast cancer patients
01:28 - Randomization and results of patients with positive circulating tumor DNA tests
02:08 - Conclusion on the utility of circulating tumor DNA for monitoring asymptomatic patient